A systematic, multidisciplinary approach to address the reproductive needs of HIV-seropositive women

Reproductive BioMedicine Online

Volumn 19, Issue 2, 2009, Pages 257-263

  Douglas, Nataki C ^a   Wang, Jeff G ^a   Yu, Bo ^a   Gaddipati, Sreedhar ^a   Guarnaccia, Michael M ^a   Sauer, Mark V ^a  

^a Columbia University ^*  (United States)

Author keywords

Fertility; HIV seropositive women; IVF

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HEALTH CARE NEED; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INTRACYTOPLASMIC SPERM INJECTION; MALE; MALE INFERTILITY; NEWBORN; PREGNANCY; PRENATAL PERIOD;

EID: 69249139939     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60082-X     Document Type: Article

References (35)

1. ACOG Committee Opinion 2001 Committee on Ethics. Human immunodeficiency virus: ethical guidelines for obstetricians and gynecologists. Obstetrics and Gynecology 97 (Suppl.), 1-6.
2. ACOG Committee Opinion 2000 Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999). International Journal of Gynaecology and Obstetrics 73, 279-281.
3. Annas GJ 1998 Protecting patients from discrimination - the Americans with Disabilities Act and HIV infection. New England Journal of Medicine 449, 1255-1259. (Pubitemid 28482143)
4. CASCADE Collaboration 2000 Concerted Action on SeroConversion to AIDS and Death in Europe. Survival after introduction of HAART in people with known duration of HIV-1 infection. Lancet 355, 1158-1159.
5. Centers for Disease Control and Prevention (CDC) 2007 HIV / AIDS Surveillance Report, 2005, vol.17. revised edn. US Department of Health and Human Services, Atlanta, pp. 1-46.
6. Clark RA, Mulligan K, Stamenovic E et al. 2001 Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies. Journal of Infectious Diseases 184, 1325-1327. (Pubitemid 33055579)
7. Cooper ER, Charurat M, Mofenson L et al. 2002 Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. Journal of Acquired Immune Deficiency Syndromes 29, 484-494. (Pubitemid 34456340)
8. Coovadia H 2004 Antiretroviral agents - how best to protect infants from HIV and save their mothers from AIDS. New England Journal of Medicine 351, 289-292. (Pubitemid 38916047)
9. Ethics Committee of the American Society for Reproductive Medicine 2004 Human immunodeficiency virus and infertility treatment. Fertility and Sterility 82 (Suppl. 1), S228-S231.
10. European Collaborative Study 2005 Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clinical Infectious Diseases 40, 458-465. (Pubitemid 40216516)
11. European Collaborative Study 1999 Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 13, 1377-1385. (Pubitemid 29408454)
12. Fantry LE, Zhan M, Taylor GH et al. 2005 Age of menopause and menopausal symptoms in HIV-infected women. AIDS Patient Care and STDS 19, 703-711. (Pubitemid 41705166)
13. Gange SJ, Barron Y, Greenblatt RM et al. 2002 Effectiveness of highly active antiretroviral therapy among HIV-1 infected women. Journal of Epidemiology and Community Health 56, 153-159. (Pubitemid 34098470)
14. Gilling-Smith C, Emiliani S, Almeida P et al. 2005 Laboratory safety during assisted reproduction in patients with blood-borne viruses. Human Reproduction 20, 1433-1438. (Pubitemid 40852231)
15. Gray, RH, Wawer MJ, Brookmeyer R et al. 2001 Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357, 1149-1153. (Pubitemid 32378686)
16. International Perinatal HIV Group 1999 The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. New England Journal of Medicine 340, 977-987.
17. Kass NE 1994 Policy, ethics, and reproductive choice: pregnancy and childbearing among HIV-infected women. Acta Paediatrica Supplement 400, 95-98.
18. Kruger TF, Acosta AA, Simmons KF et al. 1988 Predictive value of abnormal sperm morphology in in-vitro fertilization. Fertility and Sterility 49, 112-117.
19. Menkveld R, Rhemrev JP, Franken DR et al. 1996 Acrosomal morphology as a novel criterion for male fertility diagnosis: relation with acrosin activity, morphology (strict criteria), and fertilization in vitro. Fertility and Sterility 65, 637-644. (Pubitemid 26069124)
20. MMWR 2002 Update: AIDS - United States, 2000. Morbidity and Mortality Weekly Report 51, 592-595.
21. MMWR 1993 Update: barrier protection against HIV infection and other sexually transmitted diseases. Morbidity and Mortality Weekly Report 42, 589-591, 597.
22. MMWR 1988 Condoms for prevention of sexually transmitted diseases. Morbidity and Mortality Weekly Report 37, 133-137.
23. Murphy EL, Collier AC, Kalish LA et al. 2001 Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Annals of Internal Medicine 135, 17-26. (Pubitemid 32619279)
24. Nakhuda GS, Sauer MV, Wang JG et al. 2007 Müllerian inhibiting substance is an accurate marker of ovarian response in women of advanced reproductive age undergoing IVF. Reproductive BioMedicine Online 14, 450-454.
25. Perinatal HIV Guidelines Working Group 2006 Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1 Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. November 7, 2006, available on worldwide web: www.aidsinfo.nih.gov.
26. Porter K, Babiker A, Bhaskaran K et al. 2003 Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 362, 1267-1274. (Pubitemid 37324254)
27. Sauer MV 2006 American physicians remain slow to embrace the reproductive needs of human immunodeficiency virus-infected patients. Fertility and Sterility 85, 295-297.
28. Sauer MV 2003 Providing fertility care to those with HIV: time to re-examine healthcare policy. American Journal of Bioethics 3, 33-40.
29. Sauer MV, Chang PL 2002 Establishing a clinical program for human immunodeficiency virus 1-seropositive men to father seronegative children by means of in vitro fertilization with intracytoplasmic sperm injection. American Journal of Obstetrics and Gynecology 186, 627-633.
30. Seifer DB, Maclaughlin DT 2007 Müllerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertility and Sterility 88, 539-546.
31. Seifer DB, Golub ET, Lambert-Messerlian G et al. 2007 Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women. Fertility and Sterility 88, 1645-1652. (Pubitemid 350216867)
32. Stanitis JA, Grow DR, Wiczyk H 2008 Fertility services for human immunodeficiency virus-positive patients: provider policy, practice, and perspectives. Fertility and Sterility 89, 1154-1158. (Pubitemid 351681891)
33. Thorne C, Newell ML 2005 The safety of antiretroviral drugs in pregnancy. Expert Opinion on Drug Safety 4, 323-335.
34. Thorne C, Newell ML 2003 Mother-to-child transmission of HIV infection and its prevention. Current HIV Research 1, 447-462.
35. UNAIDS/WHO AIDS Epidemic Update December 2006, available at www.unaids.org.